UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines

Clinical & developmental immunology, 2010-01, Vol.2010, p.814397-8

2010

Volltextzugriff (PDF)

Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines

Journal of experimental & clinical cancer research, 2009-12, Vol.28 (1), p.146-146, Article 146

2009

Volltextzugriff (PDF)

Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data

Frontiers in oncology, 2012, Vol.2, p.150-150

2012

Volltextzugriff (PDF)

Terminally sialylated and fucosylated complex N-glycans are involved in the malignant behavior of high-grade glioma

Oncotarget, 2020-12, Vol.11 (52), p.4822-4835

2020

Volltextzugriff (PDF)

Racotumomab for treating lung cancer and pediatric refractory malignancies

Expert opinion on biological therapy, 2016-04, Vol.16 (4), p.573-578

2016

Volltextzugriff (PDF)

Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients

Cancer Immunology, Immunotherapy, 2018-08, Vol.67 (8), p.1285-1296

2018

Volltextzugriff (PDF)

Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer

Frontiers in oncology, 2012, Vol.2, p.160-160

2012

Volltextzugriff (PDF)

Minimal Disseminated Disease in Nonmetastatic Retinoblastoma With High-Risk Pathologic Features and Association With Disease-Free Survival

JAMA ophthalmology, 2016-12, Vol.134 (12), p.1374

2016

Volltextzugriff (PDF)

A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies

Pediatric blood & cancer, 2015-12, Vol.62 (12), p.2120-2124

2015

Volltextzugriff (PDF)

Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3

Oncotarget, 2018-05, Vol.9 (35), p.24069-24080

2018

Volltextzugriff (PDF)

Association of Cone-Rod Homeobox Transcription Factor Messenger RNA With Pediatric Metastatic Retinoblastoma

JAMA ophthalmology, 2015-07, Vol.133 (7), p.805

2015

Volltextzugriff (PDF)

Complete Antitumor Protection by Perioperative Immunization with GM3/VSSP Vaccine in a Preclinical Mouse Melanoma Model

Clinical cancer research, 2006-12, Vol.12 (23), p.7092-7098

2006

Volltextzugriff (PDF)

Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis

Breast cancer research and treatment, 1998-07, Vol.50 (1), p.83-93

1998

Volltextzugriff (PDF)

Practical Guidelines for Diagnostic Use of In Vitro Chemosensitivity Tests

Anticancer research, 2007-05, Vol.27 (3A), p.1365-1367

2007

Volltextzugriff (PDF)

Comparability of Antibody-Mediated Cell Killing Activity Between a Proposed Biosimilar RTXM83 and the Originator Rituximab

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2016-06, Vol.30 (3), p.225-231

2016

Volltextzugriff (PDF)

Aberrant O-glycosylation modulates aggressiveness in neuroblastoma

Oncotarget, 2018-09, Vol.9 (75), p.34176-34188

2018

Volltextzugriff (PDF)

Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: Report of a phase I trial

Cancer biology & therapy, 2007-02, Vol.6 (2), p.145-150

2007

Volltextzugriff (PDF)

1E10 anti-idiotype vaccine in non-small cell lung cancer: Experience in stage IIIb/IV patients

Cancer biology & therapy, 2007-12, Vol.6 (12), p.1847-1852

2007

Volltextzugriff (PDF)

Antitumor protection by NGcGM3/VSSP vaccine against transfected B16 mouse melanoma cells overexpressing N-glycolylated gangliosides

In vivo (Athens), 2012-07, Vol.26 (4), p.609-617

2012

Volltextzugriff (PDF)

Detection and Characterization of N-Glycolyated Gangliosides in Wilms Tumor by Immunohistochemistry

Pediatric and developmental pathology, 2010-01, Vol.13 (1), p.18-23

2010

Volltextzugriff (PDF)

Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy

Expert opinion on biological therapy, 2010-02, Vol.10 (2), p.153-162

2010

Volltextzugriff (PDF)

Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma

Molecular medicine reports, 2010-03, Vol.3 (2), p.253

2010

Volltextzugriff (PDF)

Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma

Molecular medicine reports, 2010-03, Vol.3 (2), p.253-259

2010

Volltextzugriff (PDF)

Cancer vaccines: an update with special focus on ganglioside antigens

Oncology reports, 2002-03, Vol.9 (2), p.267

2002

Volltextzugriff (PDF)

Abstract 6648: Racotumomab and PD-1 blockade combination exhibits an additive antitumor effect in a non-small cell lung cancer model

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.6648-6648

2020

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(36)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Humans
(19)
Oncology
(17)
Animals
(15)
Immunotherapy
(14)
Female
(13)
Mice
(12)
G Ganglioside - Immunology
(10)
Cancer Vaccines - Therapeutic Use
(8)
G Ganglioside - Analogs & Derivatives
(8)
Biological And Medical Sciences
(7)
Cancer Vaccines - Immunology
(7)
Immunology
(7)
Medical Sciences
(7)
Antineoplastic Agents
(6)
Immunohistochemistry
(6)
Male
(6)
Medicine, Research & Experimental
(6)
Pharmacology. Drug Treatments
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines

Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines

Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data

Terminally sialylated and fucosylated complex N-glycans are involved in the malignant behavior of high-grade glioma

Racotumomab for treating lung cancer and pediatric refractory malignancies

Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients

Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer

Minimal Disseminated Disease in Nonmetastatic Retinoblastoma With High-Risk Pathologic Features and Association With Disease-Free Survival

A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies

Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3

Association of Cone-Rod Homeobox Transcription Factor Messenger RNA With Pediatric Metastatic Retinoblastoma

Complete Antitumor Protection by Perioperative Immunization with GM3/VSSP Vaccine in a Preclinical Mouse Melanoma Model

Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis

Practical Guidelines for Diagnostic Use of In Vitro Chemosensitivity Tests

Comparability of Antibody-Mediated Cell Killing Activity Between a Proposed Biosimilar RTXM83 and the Originator Rituximab

Aberrant O-glycosylation modulates aggressiveness in neuroblastoma

Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: Report of a phase I trial

1E10 anti-idiotype vaccine in non-small cell lung cancer: Experience in stage IIIb/IV patients

Antitumor protection by NGcGM3/VSSP vaccine against transfected B16 mouse melanoma cells overexpressing N-glycolylated gangliosides

Detection and Characterization of N-Glycolyated Gangliosides in Wilms Tumor by Immunohistochemistry

Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy

Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma

Optimization of molecular detection of GD2 synthase mRNA in retinoblastoma

Cancer vaccines: an update with special focus on ganglioside antigens

Abstract 6648: Racotumomab and PD-1 blockade combination exhibits an additive antitumor effect in a non-small cell lung cancer model

Suchergebnisse filtern